Swedish investment fund earmarks capital for Medicon Valley  

Sweden's Investor AB is reportedly planning major investment initiative in Medicon Valley

Investor AB, one of Sweden's largest and most influential venture capital funds, is reported to be planning major investments in biotech and pharmaceutical companies in Medicon Valley. Financial daily Børsen reports that Investor has already conducted research into growth companies on both sides of the Øresund fixed link, and is now reviewing its findings.


Medicon Valley is one of the three largest medical and biotechnological growth centres in Europe and home to more than 60% of Scandinavia’s pharmaceutical industry. The companies in the region increased their combined workforce by no less than 30% in 2001. World class research, well educated labour, innovatory skills and increasing interest from investors have combined to put Medicon Valley ahead in the intense global competition between biotech regions.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×